Variational AI will participate in Discovery on Target (DOT) 2026, a leading conference dedicated to the latest advances in drug targets and enabling technologies for therapeutic discovery. Held annually in Boston, Discovery on Target brings together scientists from pharma, biotech, and academia to explore emerging approaches for identifying and validating novel drug targets, as well…

Learn More about Variational AI at Discovery on Target 2026

Handol Kim will speak at BioAlberta’s Health and Life Sciences Showcase in Calgary on September 24, 2026, during the Awards Dinner and Keynote.

Learn More about Handol Kim to Deliver Keynote at BioAlberta’s Health and Life Sciences Showcase

Handol Kim will join a panel at BIONATION 2026 in Ottawa on September 22, BIOTECanada’s national gathering of biotech leaders and policymakers.

Learn More about Variational AI at BIONATION 2026

Variational AI will take part in ALL IN 2026 in Montréal on September 16 and 17. Handol Kim and Valentin Beuchillot will be on site to meet partners.

Learn More about Variational AI at ALL IN 2026

Variational AI will be at the CCG North American UGM & Conference in Montreal (June 23–26, 2026). Join Alex Perryman’s scientific presentation on June 25 on how MOE supported multiple drug discovery programs.

Learn More about Variational AI at CCG’s North American UGM & Conference 2026

Variational AI will be attending BIO International Convention 2026 in San Diego. We’ll be on-site for partnering meetings to connect with pharma and biotech teams interested in accelerating small-molecule programs with generative AI—especially where speed, novelty, and multi-parameter optimization are key. Our delegation will include: Handol Kim, CEO & Co-Founder Pete Guzzo, EVP & Head…

Learn More about Variational AI at BIO International Convention 2026

Variational AI will be at VivaTech 2026, taking place June 17–20 in Paris, France, as part of the Canadian delegation led by SCALE AI.

Learn More about Variational AI at VivaTech 2026

Variational AI will be taking part in the BC Tech Annual Member Summit on June 10, 2026. Handol will share how Variational AI applies generative AI for real impact, both within the organization and in its work with partners.

Learn More about Variational AI at the BC Tech Annual Member Summit

Variational AI is joining Web Summit Vancouver 2026, one of the world’s premier technology conferences, bringing together over 20,000 attendees, investors, and innovators from across the globe, right here in Vancouver. Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, and Valentin Beuchillot, Senior Manager of BD & Marketing, will both be on the…

Learn More about Variational AI at WebSummit Vancouver 2026

Variational AI will participate in the upcoming Boston Pharmaceutical & Bioscience Society (PBSS) event, “Artificial Intelligence and Machine Learning: Shaping the Future of Therapeutic Drug Discovery, Development, and Manufacturing,” taking place April 28, 2026, in Cambridge, MA. This full-day symposium brings together leaders from biotechnology, academia, and pharmaceutical companies to discuss how artificial intelligence and…

Learn More about Variational AI to Present at PBSS Event on AI and ML in Drug Discovery

Variational AI will participate in MaRS Impact Health, a flagship health innovation event hosted by MaRS Discovery District that brings together entrepreneurs, investors, scientists, clinicians, and policymakers working to advance the future of healthcare. Meet with Variational AI If you are attending MaRS Impact Health and would like to connect with Variational AI to learn…

Learn More about Variational AI to Participate in the MaRS Impact Health Summit

Variational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies. Meet with Variational AI Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will attend the conference to meet with investors and discuss the company’s approach…

Learn More about Variational AI to Participate in the Bloom Burton Healthcare Investor Conference